Efficacy of Antiviral Treatment in Hepatitis C Virus (HCV)-Driven Monoclonal Gammopathies Including Myeloma - Archive ouverte HAL Access content directly
Journal Articles Frontiers in Immunology Year : 2022

Efficacy of Antiviral Treatment in Hepatitis C Virus (HCV)-Driven Monoclonal Gammopathies Including Myeloma

(1) , (1, 2) , (1) , (3, 4) , (3, 4) , (1) , (1) , (1) , (5) , (3, 6, 4) , (3, 7, 4) , (1, 2)
1
2
3
4
5
6
7

Abstract

Multiple myeloma (MM) remains an incurable plasma cell malignancy. While its origin is enigmatic, an association with infectious pathogens including hepatitis C virus (HCV) has been suggested. Here we report nine patients with monoclonal gammopathy of undetermined significance (MGUS) or MM with previous HCV infection, six of whom received antiviral treatment. We studied the evolution of the gammopathy disease, according to anti-HCV treatment and antigen specificity of purified monoclonal immunoglobulin, determined using the INNO LIA™ HCV Score assay, dot-blot assays, and a multiplex infectious antigen microarray. The monoclonal immunoglobulin from 6/9 patients reacted against HCV. Four of these patients received antiviral treatment and had a better evolution than untreated patients. Following antiviral treatment, one patient with MM in third relapse achieved complete remission with minimal residual disease negativity. For two patients who did not receive antiviral treatment, disease progressed. For the two patients whose monoclonal immunoglobulin did not react against HCV, antiviral treatment was not effective for MGUS or MM disease. Our results suggest a causal relationship between HCV infection and MGUS and MM progression. When HCV was eliminated, chronic antigen-stimulation disappeared, allowing control of clonal plasma cells. This opens new possibilities of treatment for MGUS and myeloma.
Fichier principal
Vignette du fichier
fimmu-12-797209.pdf (2.33 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

inserm-03531984 , version 1 (18-01-2022)

Identifiers

Cite

Alba Rodríguez-García, María Linares, María Luz Morales, Sophie Allain-Maillet, Nicolas Mennesson, et al.. Efficacy of Antiviral Treatment in Hepatitis C Virus (HCV)-Driven Monoclonal Gammopathies Including Myeloma. Frontiers in Immunology, 2022, 12, pp.797209. ⟨10.3389/fimmu.2021.797209⟩. ⟨inserm-03531984⟩
69 View
28 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More